U.S. Markets closed

Bristol-Myers, Chiromics form drug discovery strategic alliance

Chiromics LLC announced a strategic research alliance with Bristol-Myers Squibb Company which includes grants of non-exclusive license for use of Chiromics’ chemical compound library, exclusive license to a proprietary chemical compound collection, and a screening collaboration to discover and optimize novel classes of small molecules against multiple therapeutic targets.